Rep. Michael Burgess (R-Texas), the chairman of the Congressional Healthcare Caucus, used Twitter to solicit questions for a health policy forum held Monday.

The event discussed the effects of March’s healthcare overhaul on biosimilars, or new versions of biopharmaceuticals whose patents have expired.

Burgess, a former physician and a leading GOP voice against the healthcare overhaul, is also a frequent Twitter user.

He said:

Today's @HealthCaucus policy forum on biosimilars is starting shortly. Watch online at http://www.ustream.tv/channel/Health-Caucus

And tweet your questions to @HealthCaucus